Clinical Trial Update: TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and posted results of a Phase 1/2 study evaluating TRC102 in combination with Temozolomide for relapsed solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Granulosa Cell Tumor of the Ovary
• Lymphoma
• Non-small Cell Lung Cancer

Drugs mentioned

• TRC102
• Temodar (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphomas, Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-08